Page 4 - Stemcells Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vita Therapeutics, a cell engineering company harnessing the power of genetics to develop cellular therapies to treat muscular dystrophies and solid tumors, today announced the hiring of Amy Wesa, PhD, as Senior Vice President of Preclinical and Translational Research, Alexandra (Xana) Capela, PhD, as Senior Vice President of Regulatory and IND Strategy, and Michael Kuo as Senior Vice President of Manufacturing. In addition, Brown Advisory Chief Financial Officer and Chief Operating Officer David M. Churchill is newly-appointed to the Vita Therapeutics Board of Directors.

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.

How did the FDA got browbeaten into approving an Alzheimer's drug that may not work?

Stem Cell Reconstructive Market Size 2021 By Analysis, Manufacturers, Regions, Type and Application, and Forecasts to 2023

Forecasts in US$ Million by Region/Country: 2020-2027 Table 2: Stem Cell Services Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019 Table 3: Stem Cell Services Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 Table 4: Service Based (Segment) World Market by Region/Country in US$ Million: 2020 to 2027 Table 5: Service Based (Segment) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019 Table 6: Service Based (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 Table 7: T...